Latest News
14-Nov-2025 Spain’s Almirall Moves Glenmark Arm’s Skincare Drug to Phase 2 Trials
14-Nov-2025 Small Pharma Firms May Face Closure on Schedule M Mandate
13-Nov-2025 Hypertension in Youngsters Shot Up Over Last 2 Decades
12-Nov-2025 Novo Nordisk Cuts Wegovy Price by up to 37% in India to Push Sales
11-Nov-2025 Novo Nordisk Partners Emcure for Semaglutide
  more...
Latest Reports
Oct-25 Q2FY26: Steady sales growth, margin to remain flat - HDFC Securities  
Oct-25 Q2FY26 preview: Bracing for slower growth - ICICI Securities  
Oct-25 A sweeping positive move - Emkay Research  
Sep-25 Scaling capacity ahead of Semaglutide patent expiry - Motilal Oswal  
Aug-25 IPM: 7% value and 2% unit decline in Jul-25 - HDFC Securities  
  more...

Quarterly Summary June-2025
Desc Current Previous Per.Chg
Sales 72470.4 65585.7 10.5
Otherincome 2644.2 1897.0 39.4
Expense 51971.3 49147.6 5.7
RawMaterial 20024.7 18823.0 6.4
StaffCost 11094.3 10095.5 9.9
ExciseDuty 81.0 75.1 7.8
OtherExp 15645.7 15165.0 3.2
Interest 1230.9 1079.5 14.0
GrossProfit 23043.0 18465.4 24.8
Depreciation 2940.4 2761.9 6.5
Tax 4527.1 3667.4 23.4
NetProfit 14847.4 11957.8 24.2
Total.Comp 181 -- --
Source: ETIG Database

Sectoral Companies As on 14 Nov 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 421413.05
Divi's Lab 172845.11
Torrent Phar 129950.81
Cipla 123719.03
Dr.Reddy's 103903.53
Zydus Life 94980.25
Lupin 93866.69
Mankind Phar 93577.63
Aurobindo Ph 71591.12
Alkem Labora 68437.59
Abbott (I) 62099.09
Laurus Labs 53863.94
Glenmark Pha 53547.45
  click here for the complete list